Your browser doesn't support javascript.
loading
A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors.
Fukamachi, Hiroshi; Kim, Seon-Kyu; Koh, Jiwon; Lee, Hye Seung; Sasaki, Yasushi; Yamashita, Kentaro; Nishikawaji, Taketo; Shimada, Shu; Akiyama, Yoshimitsu; Byeon, Sun-Ju; Bae, Dong-Hyuck; Okuno, Keisuke; Nakagawa, Masatoshi; Tanioka, Toshiro; Inokuchi, Mikito; Kawachi, Hiroshi; Tsuchiya, Kiichiro; Kojima, Kazuyuki; Tokino, Takashi; Eishi, Yoshinobu; Kim, Yong Sung; Kim, Woo Ho; Yuasa, Yasuhito; Tanaka, Shinji.
Affiliation
  • Fukamachi H; Department of Molecular Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. hfukama.monc@gmail.com.
  • Kim SK; Personalized Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Korea.
  • Koh J; Department of Pathology, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.
  • Lee HS; Department of Pathology, Seoul National University Bundang Hospital, Gyeonggi-do, Korea.
  • Sasaki Y; Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Yamashita K; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Nishikawaji T; Department of Molecular Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Shimada S; Present Address: Division of Cancer Biology and Therapeutics, Miyagi Cancer Center Research Institute, Miyagi, 981-1293, Japan.
  • Akiyama Y; Department of Molecular Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Byeon SJ; Department of Molecular Oncology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Bae DH; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
  • Okuno K; Genome Editing Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon, Korea.
  • Nakagawa M; Department of Gastrointestinal Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Tanioka T; Department of Gastrointestinal Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Inokuchi M; Department of Gastrointestinal Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Kawachi H; Department of Gastrointestinal Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Tsuchiya K; Department of Human Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Kojima K; Present Address: Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, 135-8550, Japan.
  • Tokino T; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
  • Eishi Y; Center of Minimally Invasive Surgery, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Kim YS; Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kim WH; Department of Human Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
  • Yuasa Y; Genome Editing Research Center, Korea Research Institute of Bioscience & Biotechnology, Daejeon, Korea.
  • Tanaka S; Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
J Exp Clin Cancer Res ; 38(1): 127, 2019 Mar 12.
Article in En | MEDLINE | ID: mdl-30866995
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / TOR Serine-Threonine Kinases Limits: Animals / Humans Language: En Journal: J Exp Clin Cancer Res Year: 2019 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / TOR Serine-Threonine Kinases Limits: Animals / Humans Language: En Journal: J Exp Clin Cancer Res Year: 2019 Document type: Article Affiliation country: Japan Country of publication: United kingdom